Ad
related to: dr reddy's laboratories
Search results
Results From The WOW.Com Content Network
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy , who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited . [ 2 ]
Dr. Reddy's Laboratories (NYS: RDY) reported earnings on May 11. Here are the numbers you need to know. The 10-second takeawayFor the quarter ended March 31 (Q4), Dr. Reddy's Laboratories beat ...
Small-caps and large-caps are wildly popular among investors; however, mid-cap stocks, such as Dr. Reddy's Laboratories Limited (NSE:DRREDDY) with a market-capitalization of ₹432b, rarely draw ...
Kallam Anji Reddy (10 August 1941 – 15 March 2013) was an Indian entrepreneur in the pharmaceutical industry, the founder-chairman of Dr. Reddy's Laboratories, which he established in 1984, and chairman of Dr Reddy's Foundation (DRF), the corporate social responsibility arm of the group, established 1996.
Kallam Satish Reddy is an Indian business executive and current Chairman of Dr. Reddy's Laboratories. [ 2 ] [ 3 ] Reddy joined Dr. Reddy's Laboratories in 1993 as executive director. Elevated to the role of Managing Director in 1997, he led the company's transition from a manufacturer of active pharmaceutical ingredients to one with a diverse ...
Dr. Reddy's Laboratories Announces Dr. K. Anji Reddy Has Passed Away HYDERABAD, India--(BUSINESS WIRE)-- Dr. K. Anji Reddy, Founder & Chairman of Dr. Reddy's Laboratories Ltd., passed away this ...
Benzex was later acquired by Dr. Reddy's Laboratories. He then left the industry to focus on construction. In 1990, he reemerged in pharmaceuticals and became the CEO and MD of Cheminor Drugs Ltd. In 2001, Cheminor Drugs merged with Dr. Reddy's Laboratories [3] and Prasad took over as the vice-chairman and CEO of the merged entity. [4]
Ranbaxy competed with the maker of brand-name Zocor, Merck & Co.; IVAX Corporation (which was acquired by and merged into Teva Pharmaceutical Industries Ltd.), which has 180-day exclusivity at strengths other than 80 mg; and Dr. Reddy's Laboratories and India, whose authorized generic version (licensed by Merck) is exempt from exclusivity.